Quanterix (QTRX) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

Quanterix (QTRX) overview

Quanterix (QTRX) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 139m and operating profit of USD -126m; the year-end share price was 6.36 USD and market capitalisation was USD 297m. Quanterix is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Quanterix's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 296mFY 2025
Share price6.36 USDFY 2025 year end
RevenueUSD 139mFY 2025
Operating profitUSD -126mFY 2025
Net earningsUSD -107mFY 2025
Market capitalisationUSD 297mFY 2025 year end

About Quanterix

Quanterix provides instruments, consumables and services for biomarker research and diagnostics. Its Simoa technology detects proteins at very low concentrations in blood and other fluids, while its spatial biology platforms analyze biomarker distribution in tissue samples. The company sells products worldwide to research laboratories, contract research organizations, academic institutions and biopharmaceutical companies. It also provides contract research and clinical laboratory testing services.

Generate the Quanterix report

Quanterix is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Quanterix and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Quanterix

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.